Radnor Capital Management LLC Has $2.43 Million Position in CVS Health Co. (NYSE:CVS)

Radnor Capital Management LLC lowered its position in CVS Health Co. (NYSE:CVS) by 8.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,880 shares of the pharmacy operator’s stock after selling 3,455 shares during the quarter. Radnor Capital Management LLC’s holdings in CVS Health were worth $2,431,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CVS. Stonebridge Financial Group LLC acquired a new stake in CVS Health in the fourth quarter valued at $28,000. Hopwood Financial Services Inc. acquired a new stake in CVS Health in the fourth quarter valued at $29,000. McIlrath & Eck LLC lifted its stake in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 174 shares during the last quarter. Financial Perspectives Inc lifted its stake in CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock valued at $36,000 after acquiring an additional 466 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. lifted its stake in shares of CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 437 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE CVS opened at $63.61 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $80.47 billion, a P/E ratio of 17.38, a P/E/G ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The firm has a 50-day moving average price of $65.21 and a two-hundred day moving average price of $59.90.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the previous year, the firm posted $1.31 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. Analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.18%. The ex-dividend date was Tuesday, April 22nd. CVS Health’s dividend payout ratio (DPR) is presently 63.48%.

Analyst Ratings Changes

A number of research firms have recently issued reports on CVS. Argus set a $77.00 target price on shares of CVS Health in a research note on Tuesday, February 18th. Piper Sandler raised their target price on shares of CVS Health from $72.00 to $74.00 and gave the stock an “overweight” rating in a research note on Friday, March 21st. Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. Wolfe Research raised their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Finally, Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $74.75.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.